Novartis AG Pre-Tax Income 2010-2025 | NVS

Novartis AG pre-tax income for the twelve months ending March 31, 2025 was $14.918B, a 53.29% increase year-over-year.

  • Novartis AG annual pre-tax income for 2024 was $13.64B, a 49.51% increase from 2023.
  • Novartis AG annual pre-tax income for 2023 was $9.123B, a 27.11% increase from 2022.
  • Novartis AG annual pre-tax income for 2022 was $7.177B, a 72.54% decline from 2021.

Novartis AG Pre-Tax Income 2010-2025 | NVS

  • Novartis AG annual pre-tax income for 2024 was $13.64B, a 49.51% increase from 2023.
  • Novartis AG annual pre-tax income for 2023 was $9.123B, a 27.11% increase from 2022.
  • Novartis AG annual pre-tax income for 2022 was $7.177B, a 72.54% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$796.4B
Johnson & Johnson (JNJ)$379.5B
AbbVie (ABBV)$306B
Novo Nordisk (NVO)$260.6B
Roche Holding AG (RHHBY)$248.1B
Merck (MRK)$196.7B
Sanofi (SNY)$128.6B
Pfizer (PFE)$125.6B
Bayer (BAYRY)$23.7B
Innoviva (INVA)$1.1B